rs145623004

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_181712.5(KANK4):​c.2401T>C​(p.Tyr801His) variant causes a missense change. The variant allele was found at a frequency of 0.00115 in 1,613,918 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0013 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0011 ( 9 hom. )

Consequence

KANK4
NM_181712.5 missense

Scores

2
5
11

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts P:1U:1B:4

Conservation

PhyloP100: 6.93

Publications

8 publications found
Variant links:
Genes affected
KANK4 (HGNC:27263): (KN motif and ankyrin repeat domains 4) Predicted to be involved in negative regulation of actin filament polymerization. Located in cytosol and microtubule cytoskeleton. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0119796395).
BP6
Variant 1-62263230-A-G is Benign according to our data. Variant chr1-62263230-A-G is described in ClinVar as Likely_benign. ClinVar VariationId is 446389.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KANK4NM_181712.5 linkc.2401T>C p.Tyr801His missense_variant Exon 7 of 10 ENST00000371153.9 NP_859063.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KANK4ENST00000371153.9 linkc.2401T>C p.Tyr801His missense_variant Exon 7 of 10 1 NM_181712.5 ENSP00000360195.4
KANK4ENST00000354381.3 linkc.517T>C p.Tyr173His missense_variant Exon 6 of 9 2 ENSP00000346352.3
KANK4ENST00000371150.5 linkc.469T>C p.Tyr157His missense_variant Exon 4 of 7 2 ENSP00000360192.1
KANK4ENST00000317477.8 linkc.-186T>C 5_prime_UTR_variant Exon 1 of 4 2 ENSP00000321161.4

Frequencies

GnomAD3 genomes
AF:
0.00129
AC:
197
AN:
152124
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.0330
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000566
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00137
Gnomad OTH
AF:
0.00334
GnomAD2 exomes
AF:
0.00112
AC:
281
AN:
250780
AF XY:
0.000937
show subpopulations
Gnomad AFR exome
AF:
0.000247
Gnomad AMR exome
AF:
0.00145
Gnomad ASJ exome
AF:
0.00328
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000556
Gnomad NFE exome
AF:
0.00155
Gnomad OTH exome
AF:
0.000983
GnomAD4 exome
AF:
0.00114
AC:
1665
AN:
1461676
Hom.:
9
Cov.:
44
AF XY:
0.00117
AC XY:
851
AN XY:
727146
show subpopulations
African (AFR)
AF:
0.000359
AC:
12
AN:
33472
American (AMR)
AF:
0.00143
AC:
64
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
128
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86206
European-Finnish (FIN)
AF:
0.000786
AC:
42
AN:
53418
Middle Eastern (MID)
AF:
0.000693
AC:
4
AN:
5768
European-Non Finnish (NFE)
AF:
0.00119
AC:
1325
AN:
1111924
Other (OTH)
AF:
0.00149
AC:
90
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
86
172
258
344
430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00129
AC:
197
AN:
152242
Hom.:
1
Cov.:
31
AF XY:
0.00126
AC XY:
94
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.000385
AC:
16
AN:
41544
American (AMR)
AF:
0.00216
AC:
33
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5158
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000566
AC:
6
AN:
10602
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00137
AC:
93
AN:
68022
Other (OTH)
AF:
0.00331
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
10
20
30
40
50
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00145
Hom.:
1
Bravo
AF:
0.00130
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000997
AC:
121
EpiCase
AF:
0.00196
EpiControl
AF:
0.00231

ClinVar

Significance: Likely benign
Submissions summary: Pathogenic:1Uncertain:1Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Dec 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 27, 2017
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KANK4: BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nephrotic syndrome Pathogenic:1
Nov 10, 2017
Yale Center for Mendelian Genomics, Yale University
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

KANK4-related disorder Benign:1
Apr 01, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.71
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.26
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.12
T;T;.
Eigen
Benign
0.18
Eigen_PC
Benign
0.22
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.67
T;T;T
MetaRNN
Benign
0.012
T;T;T
MetaSVM
Benign
-0.70
T
MutationAssessor
Uncertain
2.2
M;.;.
PhyloP100
6.9
PrimateAI
Uncertain
0.59
T
PROVEAN
Uncertain
-2.7
D;D;N
REVEL
Benign
0.26
Sift
Benign
0.13
T;T;T
Sift4G
Uncertain
0.0020
D;T;T
Polyphen
0.053
B;.;D
Vest4
0.45
MVP
0.49
MPC
0.14
ClinPred
0.031
T
GERP RS
5.3
PromoterAI
0.041
Neutral
Varity_R
0.19
gMVP
0.69
Mutation Taster
=6/94
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs145623004; hg19: chr1-62728902; API